Perceptive Advisors PODD Position
Exited5-Fund ConvergencePerceptive Advisors exited their position in INSULET CORP (PODD) in Q3 2025, after holding the stock for 5 quarters.
The position was first reported in Q3 2024 and has been tracked across 5 quarterly 13F filings.
PODD is a convergence signal: 5 specialist biotech funds hold this stock, suggesting high institutional conviction.
About INSULET CORP
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Full company profile →Short Interest
5.5%
2.2 days to cover
Perceptive Advisors PODD Position History
Frequently Asked Questions
Does Perceptive Advisors own PODD?
No. Perceptive Advisors exited their position in INSULET CORP (PODD) in Q3 2025. They previously held the stock for 5 quarters.
How many hedge funds own PODD?
5 specialist biotech hedge funds currently hold PODD, including Rock Springs Capital, RTW Investments, Deerfield Management and 2 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Perceptive Advisors first buy PODD?
Perceptive Advisors's position in PODD was first reported in Q3 2024. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Perceptive Advisors's PODD position increasing or decreasing?
Perceptive Advisors completely exited their PODD position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
PODDCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Perceptive AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →